EUVIMEDEUVIMED entdecken
Open Access

Investigating predictors of progression from mild cognitive impairment to Alzheimer’s disease based on different time intervals

Yafei Wu, Xing Wang, Chenming Gu, Junmin Zhu, Ya Fang iD

Age and Ageing · 01.09.2023 · 52 (9)

DOI: 10.1093/ageing/afad182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Age and Ageing, online erschienen am 22.09.2023. Verfasst von Yafei Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Xiamen University, Xiamen, Fujian, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institute of Biomedical Imaging and Bioengineering, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mild cognitive impairment (MCI) is the early stage of AD, and about 10–12% of MCI patients will progress to AD every year. At present, there are no effective markers for the early diagnosis of whether MCI patients will progress to AD. This study aimed to develop machine learning-based models for predicting the progression from MCI to AD within 3 years, to assist in screening and prevention of high-risk populations.

Methods

Data were collected from the Alzheimer's Disease Neuroimaging Initiative, a representative sample of cognitive impairment population. Machine learning models were applied to predict the progression from MCI to AD, using demographic, neuropsychological test and MRI-related biomarkers. Data were divided into training (56%), validation (14%) and test sets (30%). AUC (area under ROC curve) was used as the main evaluation metric. Key predictors were ranked utilising their importance.

Results

The AdaBoost model based on logistic regression achieved the best performance (AUC: 0.98) in 0–6 month prediction. Scores from the Functional Activities Questionnaire, Modified Preclinical Alzheimer Cognitive Composite with Trails test and ADAS11 (Unweighted sum of 11 items from The Alzheimer’s Disease Assessment Scale-Cognitive Subscale) were key predictors.

Conclusion

Through machine learning, neuropsychological tests and MRI-related markers could accurately predict the progression from MCI to AD, especially in a short period time. This is of great significance for clinical staff to screen and diagnose AD, and to intervene and treat high-risk MCI patients early.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionHumansNeuroimagingNeuropsychological TestsROC Curve

Stichwörter der Autor:innen

Alzheimer’s diseasemachine learningmild cognitive impairmentolder peoplepredictors

Autor:innen und Institutionen

  • School of Public Health, Xiamen University, Xiamen, Fujian, China.
  • Key Laboratory of Health Technology Assessment of Fujian Province, Xiamen University, Xiamen, Fujian, China.
  • National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, Fujian, China.

ORCID-Profile: Ya Fang

Förderung

  • NIA NIH HHS
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • National Institutes of Health
  • Alzheimer's Disease Neuroimaging Initiative
  • National Key R&D Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Wu, Y., Wang, X., Gu, C., Zhu, J., & Fang, Y. (2023). Investigating predictors of progression from mild cognitive impairment to Alzheimer’s disease based on different time intervals. Age and Ageing, 52(9). https://doi.org/10.1093/ageing/afad182

Vancouver

Wu Y, Wang X, Gu C, Zhu J, Fang Y. Investigating predictors of progression from mild cognitive impairment to Alzheimer’s disease based on different time intervals. Age and Ageing. 2023;52(9). doi:10.1093/ageing/afad182

BibTeX
@article{Wu2023,
  author = {Wu, Yafei and Wang, Xing and Gu, Chenming and Zhu, Junmin and Fang, Ya},
  title = {Investigating predictors of progression from mild cognitive impairment to Alzheimer’s disease based on different time intervals},
  journal = {Age and Ageing},
  year = {2023},
  volume = {52},
  number = {9},
  doi = {10.1093/ageing/afad182}
}
Kostenlos starten →